LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
35 hedge funds and large institutions have $60.8M invested in LYRA THERAPEUTICS INC in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 12 closing their positions.
9% more capital invested
Capital invested by funds: $55.9M → $60.8M (+$4.96M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 1.07% → 1.03% (-0.05%)
20% less funds holding
Funds holding: 44 → 35 (-9)
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$917K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$601K |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$246K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$204K |
| 5 |
Two Sigma Advisers
New York
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.67M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$442K |
| 3 |
Morgan Stanley
New York
|
-$418K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$332K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$321K |
LYRA Hedge Fund Activity: Q3 2021 in Review
35 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2021, worth a combined $60.8M — up 8.9% from $55.9M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of LYRA and 3 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 7 added.
The largest buyer was Parian Global Management, opening a new position worth an estimated $917K. The largest seller was Ikarian Capital, cutting an estimated $1.67M.
- 35 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2021, down from 44 in Q2 2021.
- Funds reported $60.8M of LYRA THERAPEUTICS INC stock for Q3 2021, up 8.9% quarter-over-quarter.
- 3 funds opened new LYRA THERAPEUTICS INC positions in Q3 2021 and 12 closed out, a net change of -9 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q3 2021 was Parian Global Management, an estimated $917K added.
- The largest LYRA THERAPEUTICS INC seller in Q3 2021 was Ikarian Capital, an estimated $1.67M sold.
Based on aggregated 13F filings for Q3 2021.